The move to reduce prescription copays for Medicare beneficiaries comes as a result of the Inflation Reduction Act and will apply for the final three months of the year beginning Oct. 1, CMS said. The concept is to mitigate against drug company price increases that are above the rate of inflation.
The drug savings are for medications under Medicare Part B plans.
A list of the affected drugs can be found here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
